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Editorial Comment 
Radiofrequency Catheter Ablation 
of Benign Ventricular Ectopic 
Beats: A Therapy in Search 
of a Disease?* 
HEIN J. J. WELLENS,  MD, FACC 
Maastricht, The Netherlands 
Radiofrequency atheter ablation is increasingly used in the 
treatment of cardiac arrhythmias. Typically, thepatient has a 
tachyarrhythmia that is symptomatic and cannot be controlled 
and prevented by medication. Only occasionally, when an 
accessory atrioventricular (AV) pathway with a short antero- 
grade refractory period is found in high level competitive 
athletes or in professions such as airline pilot or bus driver, the 
arrhythmia substrate is eliminated without the patient ever 
having had a symptomatic arrhythmia. 
Ideally, the result of radiofrequency ablation leads to 
complete cure of the arrhythmia. However, there are situations 
in which radiofrequency ablation does not cure the arrhythmia, 
as in patients with atrial fibrillation a d high ventricular rates. 
Then, by interrupting or modifying AV conduction, the ar- 
rhythmia becomes better tolerated and manageable. 
Excellent results after radiofrequency ablation have been 
reported (1-5) in patients with AV node reentrant tachycar- 
dias, accessory AV pathway tachycardias and idiopathic ven- 
tricular tachycardia. Outcome after radiofrequency ablation is 
improving in patients with atrial tachycardia, atrial flutter and 
ischemic ventricular tachycardia (6-9). 
However, apart from its radiation hazard, the radiofre- 
quency ablation procedure is not without risks. Complications 
such as cardiac perforation leading to tamponade, coronary 
artery damage r sulting in myocardial infarction, damage to 
heart valves, thromboembolic complications and infection 
have been reported. In a retrospective European radiofre- 
quency catheter ablation survey in which 68 institutions volun- 
tarily participated, procedure-related complications occurred 
in 223 (5%) of 4,398 patients (10). A total of five deaths 
occurred during or within the perioperative period after the 
ablation procedure. Although the complications occurred in a 
series of patients with different ypes of arrhythmias, these 
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figures indicate that radiofrequency ablation is not an innocent 
procedure. 
In this issue of the Journal, Zhu et al. (11) report on the 
successful radiofrequency ablation of frequent, monomorphic 
ventricular ectopic beats in 10 patients. In nine patients the site 
of origin was in the outflow tract of the right ventricle. In the 
remaining patient, ectopic activity arose from the left ventric- 
ular posteroseptal region. One patient had magnetic resonance 
imaging findings suggestive of arrhythmogenic r ght ventricular 
dysplasia. One patient had "mild" cardiomyopathy and an- 
other mitral valve prolapse with mild mitral incompetence. No 
abnormalities other than the arrhythmia were present in the 
other seven patients. All patients were characterized ashaving 
frequent, medically refractory and severely symptomatic ven- 
tricular premature beats. Direct correlation between the oc- 
currence of symptoms and ventricular ectopic beats was doc- 
umented by ambulatory electrocardiography. In none of the 
patients could sustained ventricular tachycardia be evoked by 
programmed stimulation with or without isoproterenol. In all 
patients techniques similar to those currently used in patients 
with sustained ventricular tachycardia (5) were used to identify 
and ablate the site of origin of the arrhythmia. However, no 
mention is made of the fluoroscopy times and total duration of 
the procedure. In the article by Zhu et al., patients came from 
three institutions. The procedures were performed by experi- 
enced clinical electrophysiologists, and there were no compli- 
cations in this small series. The total number of patients with 
"benign" ventricular ectopic beats from whom the study 
patients were selected is not specified. It is also unclear what 
the threshold was in the three institutions for referral to 
radiofrequency ablation. 
Complaints of palpitations, fatigue and dyspnea are well 
known to the physician who cares for patients with benign 
ventricular ectopic beats. It is important that the physician 
understand the anxiety and agony of doubt that often accom- 
panies cardiac ectopic activity. However, in my experience 
most patients do not require medication if they can be 
reassured by appropriate (and sometimes frequent) counsel- 
ing. When medication is required, a beta-blocking drug or a 
calcium antagonist uch as verapamil or diltiazem are selected 
because of their low risk profile. 
Recently, Gumbrielle et al. (12) published a case report 
under the title: "Is ventricular ectopy a legitimate target for 
ablation?" In an editorial in the same issue Garrett (13) 
concluded that radiofrequency ablation is a rare indication for 
the treatment of ventricular extrasystole. The article by Zhu et 
al. suggests hat cardiologists may differ about the indication 
for radiofrequency ablation of benign ventricular ectopic beats. 
It is clear that life expectancy will not improve by successful 
radiofrequency ablation in these patients because the long- 
term prognosis of benign ventricular ectopic beats is excellent. 
I am concerned that some of our colleagues will accept he 
article by Zhu et al. as an invitation to approach bothersome 
but otherwise innocent ventricular ectopic activity by catheter 
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ablation. That situation may develop into a therapy in search of 
a disease rather than the reverse! 
The best solution would seem to be a randomized study in 
a series of patients fulfilling stringent criteria as to incidence 
and complaints of their benign ventricular ectopic activity 
comparing antiarrhythmic drug therapy and radiofrequency 
catheter ablation treatment. Such a study will give us an idea 
about complications, long-term efficacy, costs and the patient's 
quality of life of both modes of treatment and is in my opinion 
required before benign ventricular premature beats can be 
considered an indication for radiofrequency catheter ablation. 
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